pharmaphorum

DECEMBER 11, 2022

Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.

Life Science 137

Life Science Clinical Research Development Research 137

Pharmaceutical Technology

DECEMBER 21, 2022

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery. But as the field grows in leaps and bounds, many authorities have prioritised the release of new guidelines, frameworks, and regulations to keep pace with these advances.

Regulation 351

Regulation Pharma Companies Medicine Clinical Trials 351

Bio Pharma Dive

DECEMBER 19, 2022

The OK caps a long development journey for the treatment, which was previously turned back by the agency. Ferring doesn’t expect it to be available until the second half of next year, however.

Gene Therapy 353

Gene Therapy FDA Approval Gene Development 353

Pharma Mirror

DECEMBER 16, 2022

The COVID-19 pandemic challenged researchers to discover life-saving treatments at an unprecedented pace. While these researchers rose to the occasion by discovering drugs faster than ever before, variants continue to challenge the world in addressing COVID-19. New innovations in computer-aided drug discovery tools could dramatically accelerate the study of new variants.

Research 264

Research Drugs Scientist 264

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 15, 2022

Severe COVID-19 looks scarily like old age in the human brain, according to a postmortem analysis of 54 healthy and infected individuals. The authors of the study say their research is the first to link COVID-19 to molecular signatures of brain aging. “We observed that gene expression in the brain tissue of patients who died […].

Gene Expression 246

Gene Expression Gene Research Clinical Trials 246

NPR Health - Shots

DECEMBER 31, 2022

Since the return of the Taliban, Afghanistan's coal exports have increased — and so has child labor. At a coal mine in Baghlan province, boys earn between $3 and $8 for a day's work.

145

145

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The latest development comes after the parties announced an agreement in principle in June this year. This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure.

Gene Therapy 351

Gene Therapy Vaccine Vaccination Manufacturing 351

Bio Pharma Dive

DECEMBER 1, 2022

The regulatory OK, a milestone for microbiome-based drug research, is for a medicine from Ferring Pharma that treats a recurrent type of gut infection.

FDA Approval 358

FDA Approval Medicine Drugs Research 358

Medical Xpress

DECEMBER 20, 2022

Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

Development 145

Development Medicine Research Cardiology 145

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 22, 2022

Athletes scaled new heights during the 2020 Tokyo Olympics with the addition of seven new sports, including karate and climbing. But while overall injuries remained comparable to previous games, some of the new sports contributed a disproportionately large portion of them. [link] To safeguard athletes’ wellbeing the International Olympic Committee (IOC) audits injuries and illnesses […].

Clinical Trials 246

Clinical Trials Clinical Trials Clinical Research Trials 246

Advertisement

Clinical Supply

NPR Health - Shots

DECEMBER 23, 2022

A team of researchers' study suggests that COVID-19 health leaders incorporate exercise into their mitigation strategies.

Research 145

Research 145

STAT News

DECEMBER 14, 2022

Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker and ProPublica documented outright fraud, predatory practices, and flagrant mistreatment by specific publicly traded and private equity-owned hospice companies.

145

145

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The companies entered the initial agreement in September last year. This alliance is utilising the Axiomer ribonucleic acid (RNA) editing platform of ProQR to address ailments affecting the liver and nervous system.

Genetics 328

Genetics Medicine Development Gene Therapy 328

Bio Pharma Dive

DECEMBER 6, 2022

In an interview with BioPharma Dive, the longtime industry executive discussed becoming a biotech investor and his plans for Abio-X, a new incubator with $150 million to spend on startups.

348

348

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Medical Xpress

DECEMBER 12, 2022

Reasons underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents according to a new study in The American Journal of Medicine. Researchers found that adults who neglect these health recommendations may also neglect basic road safety. They recommend that greater awareness might encourage more COVID-19 vaccination.

Vaccine 145

Vaccine Vaccination Medicine Research 145

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 20, 2022

Restricting our food intake can result in a range of health benefits, including reducing the risk of obesity. But when the dieting stops, the weight often piles back on, and a new study in mice may have identified why. [link] Scientists from the Shanghai Institute of Nutrition and the Chinese Academy of Sciences think they […].

Bacteria 245

Bacteria Scientist Clinical Trials Clinical Trials 245

NPR Health - Shots

DECEMBER 21, 2022

A new report shows the pandemic and the overdose crisis helped push down the average life expectancy in the U.S. for a second year in a row.

145

145

STAT News

DECEMBER 14, 2022

Almost 90% of the health care companies deemed to be under financial stress by a leading credit rating agency are owned by private equity , a stark indicator of the toll financial investors have taken on a vital sector. The striking finding is part of a new Moody’s Investors Service report released this week that shows broad turbulence throughout an industry weakened by private equity’s practice of loading companies with debt, making them less resilient to challenges like Covid-19,

145

145

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccine 306

Bio Pharma Dive

DECEMBER 12, 2022

After outlasting rival suitors Sanofi and J&J in deal talks, Amgen agreed to a deal that values the Ireland-based maker of rare and inflammatory disease drugs at about $28 billion.

Drugs 345

Drugs 345

pharmaphorum

DECEMBER 19, 2022

A collaboration between academic centres in the UK has won government funding for a digital approach to dysfunctional breathing or dyspnoea, a symptom that affects around 10% of the population. The Engineering and Physical Sciences Research Council (EPSRC) has set aside £400,000 (almost $490,000) for the project, which will help fund work at the Universities of Plymouth, Salford and Stirling, and the Glasgow School of Art.

Engineer 145

Engineer Research Development 145

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 11, 2022

A ping from the pizza company. A couple of pings from your socials. Ping, ping, ping from your family WhatsApp group trying to organize a weekend barbecue. With all those smartphone notifications, it’s no wonder you lose focus on what you’re trying to do do. Your phone doesn’t even need to ping to distract you. […].

Clinical Trials 244

Clinical Trials Clinical Trials Clinical Research Trials 244

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

NPR Health - Shots

DECEMBER 15, 2022

Scientists predict China will see the largest COVID surge of the pandemic this winter, with hundreds of millions of people infected. But some experts say that it could have been even worse.

Scientist 145

Scientist 145

STAT News

DECEMBER 10, 2022

Whenever a hematopoietic cell transplant patient tries to get a family member to sneak food in past the nurses, Federico Stella, a resident hematologist at the University of Milan, remembers. One was a girl who tried to get her sister to bring her a panettone, a Milanese sweet bread usually eaten around the holidays. A week before Christmas, the sister tried to hide the panettone in a bag.

Nurses 145

Nurses 145

Pharmaceutical Technology

DECEMBER 8, 2022

Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Subsequently, in the same year, Gilead Sciences acquired Kite.

Licensing 305

Licensing Licensing Gene Therapy Gene 305

Bio Pharma Dive

DECEMBER 8, 2022

As the success of drugs like Enhertu catalyzes new investment in antibody-drug conjugates, the California startup is launching with plans to develop more potent versions of the targeted cancer medicines.

Drugs 334

Drugs Antibody Medicine Development 334

Advertiser: FourKites

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

Research

Medical Xpress

DECEMBER 20, 2022

Probiotic bacteria usually found in fermented foods, such as yogurt, sourdough bread, and miso soup, might help dispel the embarrassment of persistent bad breath (halitosis), finds a pooled data analysis of the available evidence, published in the open access journal BMJ Open.

Bacteria 145

Bacteria 145

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 13, 2022

Research suggests there could be a “simple, safe, and economical” way to relieve pain: green light. And a new animal study reveals the biological underpinnings of how it might work. Scientists have been exploring the pain-relieving effects of green light for at least half a decade, uncovering an occasional clue on exactly how it happens. […].

Scientist 243

Scientist Research Clinical Trials Clinical Trials 243

NPR Health - Shots

DECEMBER 15, 2022

People are gathering indoors for the holidays, and there's been an uptick in COVID-19 cases. The federal government says you should test often to try to prevent the spread of the virus.

145

145

STAT News

DECEMBER 9, 2022

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson. The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech.

145

145

Speaker: Steve Goldstein, Sales Leader

Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g

Sales